Alyson Wright
Family · Portsmouth, OHNPI 1922740240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 29.2% of the total. 2025 is the largest year on record at $1,114, 3.5 times the $319 reported in 2022.
Across 195 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$863
- AbbVie$651
- Neurocrine Biosciences, Inc.$469
- Axsome Therapeutics, Inc.$201
- Johnson & Johnson$167
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$111
- plus $492 from 8 others
What the payments were for
- Food & beverage$2,953100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 56 | $863 |
| AbbVie | 73 | $651 |
| Neurocrine Biosciences, Inc. | 18 | $469 |
| Axsome Therapeutics, Inc. | 7 | $201 |
| Johnson & Johnson | 8 | $167 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $111 |
| Teva Pharmaceuticals USA, Inc. | 7 | $105 |
| Lundbeck LLC | 6 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $84 |
| Supernus Pharmaceuticals, Inc. | 4 | $67 |
| Atricure, Inc. | 3 | $51 |
| Alkermes, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
How this compares
$2,953 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vilazodone Hcl | 19 | $1,403 |
| Oxcarbazepine | 17 | $680 |
| Duloxetine Hcl | 15 | $397 |
| Fluoxetine Hcl | 15 | $261 |
| Propranolol Hcl | 19 | $232 |
| Hydroxyzine Hcl | 24 | $198 |
| Prazosin Hcl | 21 | $164 |
| Aripiprazole | 14 | $136 |
| Trazodone Hcl | 27 | $126 |
| Buspirone Hcl | 12 | $125 |
| Paroxetine Hcl | 11 | $101 |
| Clonazepam | 21 | $85 |
| Risperidone | 13 | $66 |
| Clonidine Hcl | 18 | $49 |
| Zolpidem Tartrate | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other family in Portsmouth
- Thea FloydPortsmouth$23K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.